IHS Holding Limited
IHSIHS Holding Limited's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup.
Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding.
The price is in a confirmed uptrend (68 weeks in). But the balance sheet is under water: net worth is negative, so shareholders sit behind everyone the company owes. What settles it: whether the business can earn its way back to positive equity before dilution or restructuring gets there first.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
IHS Holding Limited trades at $8.2, in a confirmed uptrend and 68 weeks into that stage. That is +5.0% against its own 200-day average. It sits at 92% of a 52-week range of $6 to $8. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (15 weeks and counting).
Today the stock is in a confirmed uptrend — week 68 of stage 2. At $8.2 it trades +5.0% versus its 200-day average and sits at 92% of its 52-week range ($6–$8).
Against the market, two honest reads. Cumulative: over the last 4.8 years the stock moved −51% while the S&P 500 moved +73% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (15 weeks and counting; last ahead the week of 2026-04-24) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
IHS Holding Limited trades at 4.4× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 4.4× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
IHS Holding Limited reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
The return-on-capital curve is not shown — net worth is negative, so a return on capital is not a meaningful number in any basis. This is a distressed balance sheet, and the stage is read from the growth curves alone.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +3.3% | −6.9% | — | — |
| Stock price | +26.5% | +1.5% | — | — |
4-Factor Sector Score
48.9/100 — rank 9 of 27 in Real Estate Services · 64% evidence confidence
IHS Holding Limited scores 48.9 out of 100 against the 27 companies it is compared with in Real Estate Services, ranking 9. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 12.2 + 15.2 + 10.8 + 10.7 = 48.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
IHS Holding Limited reported $0.4 B of revenue in the Mar 26 quarter, +7.7% year on year. That is the 3rd straight quarter of year-on-year growth. Over 4 years it has compounded at 0.0% a year. The last full year, FY25, came in at $1.6 B. The last four reported quarters add to $1.7 B.
FY25 revenue came in at $1.6 B (+3.3% on the year), capping 4 years at 0.0% compound. The latest quarter (Mar 26) printed $0.4 B, +7.7% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +4.4% growth against the decade's 0.0% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +4.3% over the last 4 quarters against −6.4%/yr over the last 8 — accelerating.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
IHS Holding Limited's operating margin is 26.2% in the Mar 26 quarter, −17.4 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 15.8% to 51.9%. The current quarter sits inside that band.
The latest quarter's operating margin is 26.2%, −17.4 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 15.8%–51.9%, and FY25's 51.9% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −17.4 pp year on year while gross margin went −1.6 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
IHS Holding Limited earned $0.1 B of net profit in the Mar 26 quarter, +40.0% year on year. Full-year FY25 profit was $0.1 B. That is 16.7% of the quarter's revenue. The same quarter a year earlier earned $0.1 B. 7 of the last 12 reported quarters were loss-making.
Mar 26 profit was $0.1 B, +40.0% year on year. On the full year, FY25 printed $0.1 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
IHS Holding Limited's cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $0.9 B of operating cash against $0.1 B of profit. After $0.3 B of capital spending, $0.7 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of $0.9 B against reported profit of $0.1 B, leaving free cash of $0.7 B after $0.3 B of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
IHS Holding Limited does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 21.1% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $1.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
IHS Holding Limited earns a ROE of −144% in FY25. That is up from a trough of −569% in FY23. Return on invested capital clears the cost of that capital by +8.0 percentage points, so growth here adds value rather than only size. The wiring behind it is 8.2% net margin on 0.35× asset turns.
FY25 ROE is −144%, recovered from a FY23 trough of −569% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 8.2% net margin × 0.35× asset turns × −49.89× balance-sheet leverage ≈ −143.2% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 16.1% − 8.1% = a +8.0 pp spread. The 8.1% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.
Dividend
IHS Holding Limited pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
IHS Holding Limited does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
IHS Holding Limited's net worth is negative — it owes more than it owns — so a debt-to-equity ratio is not meaningful here. On the annual view that ratio went from 1.72 in FY21 to −39.00 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of $3.5 B against shareholder equity of $−0.0 B — a debt-to-equity of −175.00. On the annual view, debt-to-equity went from 1.72 (FY21) to −39.00 (FY25). The returns on this page are earned, not borrowed.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
1.6% of IHS Holding Limited's tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 1.3 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 1.6% of the float is sold short, and at typical trading volumes it would take about 1.3 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
IHS Holding Limited: the Z-score reads −0.61. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of −0.61 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads −0.61.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Jones Lang LaSalle IncorporatedJLL | 64.8/100Thin evidence · provisional58% evidence | TURNING | 21.3/35 Revenue — · PAT — · OPM change 1.1 pp 45% evidence | 14.8/25 ROCE 2.8% · OPM 3.2% 76% evidence | 10.9/20 P/E 14.9× · PEG — 15% evidence | 17.8/20 RS sector 17.1% · RS bench 4.1% · 1Y 32.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 14.8 + 10.9 + 17.8 = 64.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2The RMR Group Inc.RMR | 60.7/100Mixed-positive evidence75% evidence | ASLEEP | 16.0/35 Revenue -20.4% · PAT 0% · OPM change 0.3 pp 83% evidence | 14.3/25 ROCE 1.2% · OPM 4.8% 76% evidence | 16.2/20 P/E 12.8× · PEG 0.46 65% evidence | 14.2/20 RS sector 11.1% · RS bench -0.5% · 1Y 18.4%10 of 12 weeks ahead 70% evidence |
| Exact sum: 16 + 14.3 + 16.2 + 14.2 = 60.7 · Decision use: Price leads the evidence: RS versus the benchmark is -0.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 3CBRE Group, Inc.CBRE | 56.6/100Thin evidence · provisional58% evidence | BASING | 19.8/35 Revenue — · PAT — · OPM change 1.8 pp 45% evidence | 15.4/25 ROCE 2% · OPM 4.9% 76% evidence | 10.2/20 P/E 30.9× · PEG — 15% evidence | 11.2/20 RS sector 1.8% · RS bench -10% · 1Y -2.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 15.4 + 10.2 + 11.2 = 56.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Star HoldingsSTHO | 53.7/100Thin evidence · provisional58% evidence | TURNING | 21.3/35 Revenue 11.5% · PAT — · OPM change 21.4 pp 62% evidence | 7.1/25 ROCE -1.2% · OPM -29.6% 76% evidence | 11.5/20 P/E 2.3× · PEG — 15% evidence | 13.8/20 RS sector 10.9% · RS bench -1% · 1Y 26.6%4 of 12 weeks ahead 70% evidence |
| Exact sum: 21.3 + 7.1 + 11.5 + 13.8 = 53.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5FirstService CorporationFSV | 53.6/100Thin evidence · provisional58% evidence | TURNING | 20.0/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence | 15.7/25 ROCE 2.9% · OPM 3.5% 76% evidence | 9.7/20 P/E 40.3× · PEG — 15% evidence | 8.2/20 RS sector -8.7% · RS bench -19.5% · 1Y -28.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 15.7 + 9.7 + 8.2 = 53.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Marcus & Millichap, Inc.MMI | 53.0/100Thin evidence · provisional58% evidence | ASLEEP | 22.3/35 Revenue 9.7% · PAT — · OPM change 8.8 pp 62% evidence | 8.4/25 ROCE -0.8% · OPM -3.4% 76% evidence | 9.4/20 P/E 47.7× · PEG — 15% evidence | 12.9/20 RS sector 8.3% · RS bench -3.7% · 1Y 6.4%6 of 12 weeks ahead 70% evidence |
| Exact sum: 22.3 + 8.4 + 9.4 + 12.9 = 53 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7CoStar Group, Inc.CSGP | 50.1/100Thin evidence · provisional58% evidence | BASING | 22.9/35 Revenue — · PAT — · OPM change 6.2 pp 45% evidence | 12.3/25 ROCE 0.8% · OPM 0.3% 76% evidence | 9.3/20 P/E 149.1× · PEG — 15% evidence | 5.6/20 RS sector -44.2% · RS bench -51.8% · 1Y -68.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.9 + 12.3 + 9.3 + 5.6 = 50.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Newmark Group, Inc.NMRK | 49.6/100Thin evidence · provisional58% evidence | BASING | 20.6/35 Revenue — · PAT — · OPM change 5.8 pp 45% evidence | 13.3/25 ROCE 1.3% · OPM 3.2% 76% evidence | 10.5/20 P/E 18.7× · PEG — 15% evidence | 5.2/20 RS sector -2.6% · RS bench -13.9% · 1Y -2.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.6 + 13.3 + 10.5 + 5.2 = 49.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9IHS Holding Limitedthis pageIHS | 48.9/100Mixed-negative evidence64% evidence | ASLEEP | 12.2/35 Revenue 3.7% · PAT — · OPM change -15.5 pp 62% evidence | 15.2/25 ROCE 3.2% · OPM 26.8% 76% evidence | 10.8/20 P/E 15.5× · PEG — 15% evidence | 10.7/20 RS sector 7.5% · RS bench -3.8% · 1Y 23.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.2 + 15.2 + 10.8 + 10.7 = 48.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Transcontinental Realty Investors, Inc.TCI | 48.5/100Mixed-negative evidence75% evidence | BREAKING OUT | 14.8/35 Revenue 2.1% · PAT 0% · OPM change -10.6 pp 83% evidence | 9.8/25 ROCE -0.2% · OPM -15.9% 76% evidence | 15.0/20 P/E 32× · PEG 0.54 65% evidence | 8.9/20 RS sector -0.9% · RS bench -12.5% · 1Y 4.4%6 of 12 weeks ahead 70% evidence |
| Exact sum: 14.8 + 9.8 + 15 + 8.9 = 48.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 11Compass, Inc.COMP | 47.7/100Mixed-negative evidence64% evidence | BREAKING OUT | 14.9/35 Revenue 40.1% · PAT — · OPM change -9 pp 62% evidence | 4.2/25 ROCE -8.9% · OPM -13% 76% evidence | 9.0/20 P/E 365.5× · PEG — 15% evidence | 19.6/20 RS sector 27% · RS bench 12.7% · 1Y 47.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 14.9 + 4.2 + 9 + 19.6 = 47.7 · Decision use: Price leads the evidence: RS versus the benchmark is 12.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 12Colliers International Group Inc.CIGI | 47.3/100Thin evidence · provisional58% evidence | BASING | 17.3/35 Revenue — · PAT — · OPM change -0.1 pp 45% evidence | 14.1/25 ROCE 1.8% · OPM 2.7% 76% evidence | 9.6/20 P/E 44.6× · PEG — 15% evidence | 6.3/20 RS sector -21.1% · RS bench -30.9% · 1Y -37%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.3 + 14.1 + 9.6 + 6.3 = 47.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Cushman & Wakefield LimitedCWK | 46.6/100Mixed-negative evidence71% evidence | BASING | 18.3/35 Revenue 10.4% · PAT -53.8% · OPM change 0.3 pp 83% evidence | 11.8/25 ROCE 1.1% · OPM 2.3% 76% evidence | 9.9/20 P/E 38.3× · PEG — 15% evidence | 6.6/20 RS sector -2.5% · RS bench -13.9% · 1Y 2.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 11.8 + 9.9 + 6.6 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14American Realty Investors, Inc.ARL | 43.1/100Thin evidence · provisional58% evidence | TURNING | 15.0/35 Revenue 4.2% · PAT — · OPM change -11 pp 62% evidence | 9.1/25 ROCE -0.2% · OPM -17.8% 76% evidence | 10.3/20 P/E 20.3× · PEG — 15% evidence | 8.7/20 RS sector -1.2% · RS bench -12.2% · 1Y 20%5 of 12 weeks ahead 70% evidence |
| Exact sum: 15 + 9.1 + 10.3 + 8.7 = 43.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15The Real Brokerage Inc.REAX | 42.8/100Thin evidence · provisional55% evidence | BASING | 23.9/35 Revenue 46.8% · PAT — · OPM change 0.8 pp 62% evidence | 5.2/25 ROCE -7% · OPM -0.7% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.7/20 RS sector -42.9% · RS bench -50.6% · 1Y -55.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 23.9 + 5.2 + 10 + 3.7 = 42.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Seaport Entertainment Group Inc.SEG | 41.4/100Thin evidence · provisional55% evidence | BREAKING OUT | 12.3/35 Revenue 13.4% · PAT — · OPM change -130.3 pp 62% evidence | 3.8/25 ROCE -7% · OPM -333.8% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 15.3/20 RS sector 15.9% · RS bench 3.3% · 1Y 13%8 of 12 weeks ahead 70% evidence |
| Exact sum: 12.3 + 3.8 + 10 + 15.3 = 41.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17RE/MAX Holdings, Inc.RMAX | 38.7/100Mixed-negative evidence74% evidence | ASLEEP | 9.2/35 Revenue -5% · PAT -90% · OPM change -18.3 pp 62% evidence | 7.5/25 ROCE -1.8% · OPM -11.1% 76% evidence | 8.7/20 P/E 576× · PEG 1.66 65% evidence | 13.3/20 RS sector 17% · RS bench 4.2% · 1Y 20.5%10 of 12 weeks ahead 100% evidence |
| Exact sum: 9.2 + 7.5 + 8.7 + 13.3 = 38.7 · Decision use: Price leads the evidence: RS versus the benchmark is 4.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 18FRP Holdings, Inc.FRPH | 38.0/100Mixed-negative evidence65% evidence | TURNING | 11.7/35 Revenue 4.8% · PAT -85.7% · OPM change -17.8 pp 83% evidence | 10.9/25 ROCE 0.1% · OPM 4.8% 76% evidence | 8.7/20 P/E 547× · PEG — 15% evidence | 6.7/20 RS sector -3.7% · RS bench -14.5% · 1Y -13.5%0 of 12 weeks ahead 70% evidence |
| Exact sum: 11.7 + 10.9 + 8.7 + 6.7 = 38 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19AGNT, IncAGNT | 37.9/100Thin evidence · provisional58% evidence | ASLEEP | 18.6/35 Revenue 5.3% · PAT — · OPM change 0.2 pp 62% evidence | 7.5/25 ROCE -3.8% · OPM -0.9% 76% evidence | 8.8/20 P/E 406× · PEG — 15% evidence | 3.0/20 RS sector -46.1% · RS bench -53.2% · 1Y -57.6%0 of 12 weeks ahead 70% evidence |
| Exact sum: 18.6 + 7.5 + 8.8 + 3 = 37.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Maui Land & Pineapple Company, Inc.MLP | 37.4/100Mixed-negative evidence65% evidence | TURNING | 11.4/35 Revenue 20% · PAT -500% · OPM change -28.5 pp 83% evidence | 4.9/25 ROCE -5.5% · OPM -59.2% 76% evidence | 9.1/20 P/E 239.2× · PEG — 15% evidence | 12.0/20 RS sector 6.6% · RS bench -5.2% · 1Y 4.9%4 of 12 weeks ahead 70% evidence |
| Exact sum: 11.4 + 4.9 + 9.1 + 12 = 37.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Douglas Elliman Inc.DOUG | 32.3/100Thin evidence · provisional58% evidence | ASLEEP | 9.7/35 Revenue -5.3% · PAT — · OPM change -6.1 pp 62% evidence | 6.3/25 ROCE -4.8% · OPM -8.2% 76% evidence | 11.1/20 P/E 13.9× · PEG — 15% evidence | 5.2/20 RS sector -20.5% · RS bench -30.3% · 1Y -21.4%1 of 12 weeks ahead 70% evidence |
| Exact sum: 9.7 + 6.3 + 11.1 + 5.2 = 32.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 22Seritage Growth PropertiesSRG | 31.0/100Thin evidence · provisional51% evidence | ASLEEP | 9.2/35 Revenue 0% · PAT — · OPM change -635.5 pp 62% evidence | 7.3/25 ROCE -4.2% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.5/20 RS sector -22.5% · RS bench -32% · 1Y -15%0 of 12 weeks ahead 70% evidence |
| Exact sum: 9.2 + 7.3 + 10 + 4.5 = 31 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Opendoor Technologies Inc.OPEN | 23.0/100Adverse evidence61% evidence | ASLEEP | 7.9/35 Revenue -23.2% · PAT — · OPM change -17.2 pp 62% evidence | 4.0/25 ROCE -7.5% · OPM -22.1% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 1.1/20 RS sector -27.1% · RS bench -36.1% · 1Y 111.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 7.9 + 4 + 10 + 1.1 = 23 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Comstock Holding Companies, Inc.CHCI | 64.1/100Thin evidence · provisional47% evidence | BASING | 23.0/35 Revenue 24.1% · PAT 13.3% · OPM change — 45% evidence | 13.6/25 ROCE — · OPM — 15% evidence | 15.9/20 P/E 11.4× · PEG 0.83 65% evidence | 11.6/20 RS sector 5.6% · RS bench -5.7% · 1Y 11.9%4 of 12 weeks ahead 70% evidence |
| Exact sum: 23 + 13.6 + 15.9 + 11.6 = 64.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25Rafael Holdings, Inc.RFL | 54.8/100Thin evidence · provisional24% evidence | BREAKING OUT | 16.3/35 Revenue — · PAT — · OPM change — 8% evidence | 10.9/25 ROCE — · OPM — 15% evidence | 10.6/20 P/E 18.1× · PEG — 15% evidence | 17.0/20 RS sector 34.8% · RS bench 20.9% · 1Y 23.5%9 of 12 weeks ahead 70% evidence |
| Exact sum: 16.3 + 10.9 + 10.6 + 17 = 54.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26New England Realty Associates Limited PartnershipNEN | 43.7/100Thin evidence · provisional48% evidence | BASING | 11.8/35 Revenue 14.8% · PAT -112.5% · OPM change -23.9 pp 83% evidence | 11.9/25 ROCE 0.4% · OPM 6.2% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y -20.2%0 of 10 weeks ahead 0% evidence |
| Exact sum: 11.8 + 11.9 + 10 + 10 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 27Hotel101 Global Holdings Corp.HBNB | 43.1/100Thin evidence · provisional29% evidence | ASLEEP | 18.3/35 Revenue — · PAT — · OPM change — 9% evidence | 8.9/25 ROCE -1.7% · OPM — 46% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.9/20 RS sector -7.9% · RS bench -17.5% · 1Y 213.7%0 of 12 weeks ahead 70% evidence |
| Exact sum: 18.3 + 8.9 + 10 + 5.9 = 43.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is IHS Holding Limited's stock price today?
IHS Holding Limited trades at $8.2, +26.5% over the past year. The company is valued at $3.0 B. The stock sits at 92% of its 52-week range of $6–$8, +5.0% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 68 weeks in. — as of 5 August 2026.
What were IHS Holding Limited's latest quarterly results?
IHS Holding Limited reported revenue of $0.4 B and net profit of $0.1 B for the Mar 26 quarter. Revenue rose 7.7% and profit rose 40.0% year on year. Earnings per share were $0.22. The operating margin was 26.2%, 17.4 pp lower than a year earlier. — as of 5 August 2026.
What is IHS Holding Limited's revenue?
IHS Holding Limited reported revenue of $0.4 B in the Mar 26 quarter, +7.7% year on year. For the full FY25 fiscal year, revenue was $1.6 B (+3.3%). Over the last 4 years revenue compounded at 0.0% a year. — as of 5 August 2026.
What is IHS Holding Limited's profit?
IHS Holding Limited earned $0.1 B of net profit in the Mar 26 quarter, +40.0% year on year. Full-year FY25 profit was $0.1 B. The operating margin ran 26.2% in the latest quarter. — as of 5 August 2026.
What is IHS Holding Limited's market cap?
IHS Holding Limited's market capitalisation is $3.0 B at a stock price of $8.2. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does IHS Holding Limited pay a dividend?
No — IHS Holding Limited has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is IHS Holding Limited growing?
Yes — IHS Holding Limited is growing: latest-quarter revenue +7.7% year on year, profit +40.0%, and the margin −17.4 pp at 26.2%. The earnings engine currently reads: improving — as of 5 August 2026.
How is IHS Holding Limited performing?
IHS Holding Limited is in a confirmed uptrend, 68 weeks in. Its latest quarter's revenue rose 7.7% and profit rose 40.0% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 15 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
Is IHS Holding Limited in an uptrend?
Yes — the price is in a confirmed uptrend (week 68 of stage 2), trading +5.0% versus its 200-day average and at 92% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is IHS Holding Limited beating the market?
Not lately — on a trailing-13-week view IHS Holding Limited is currently behind the S&P 500 (15 weeks and counting; last ahead the week of 2026-04-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 4.8 years the stock moved −51% against the S&P 500's +73% — behind the index over the full window. — as of 5 August 2026.
Will IHS Holding Limited's stock price go up?
This page publishes no price forecast for IHS Holding Limited. What it measures instead: the stock price is $8.2, the price is in a confirmed uptrend 68 weeks in. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against IHS Holding Limited?
No — short interest is 1.6% of IHS Holding Limited's tradable float, about 1.3 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
What is IHS Holding Limited's capex?
IHS Holding Limited spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.3 B. — as of 5 August 2026.
What is IHS Holding Limited's cash flow?
IHS Holding Limited generated $0.9 B of operating cash flow in FY25 and $0.7 B of free cash flow after $0.3 B of capital spending. Reported profit that year was $0.1 B, so operating cash ran ahead of profit. — as of 5 August 2026.
How financially safe is IHS Holding Limited?
On the balance sheet, the Z-score reads −0.61 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.
Where is IHS Holding Limited in its business cycle?
IHS Holding Limited's FY25 operating margin was 51.9%, against a 5-year band of 15.8%–51.9%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 26.2%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the IHS Holding Limited story?
Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is IHS Holding Limited a stock worth studying right now?
This is not investment advice. The machine read: IHS Holding Limited's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup. The sharpest open question: whether the business can earn its way back to positive equity before dilution or restructuring gets there first. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.